The optimal time for the initiation of in vitro fertilization and embryo transfer among women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertility-sparing treatment

Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer

(2021) Olga V. Novikova et al.   GYNECOLOGIC ONCOLOGY

Autophagy in Female Fertility: A Role in Oxidative Stress and Aging

(2020) Alexandra E. Peters et al.   ANTIOXIDANTS & REDOX SIGNALING

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Comparison Between PPOS and GnRHa-Long Protocol in Clinical Outcome with the First IVF/ICSI Cycle: A Randomized Clinical Trial

(2020) Qianwen Xi et al.   Clinical Epidemiology

Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses

(2020) Baris Ata et al.   HUMAN REPRODUCTION UPDATE

Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer

(2019) Su Hyun Chae et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Outcomes of in vitro fertilization cycles following fertility-sparing treatment in stage IA endometrial cancer

(2019) Myung Joo Kim et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia

(2016) Osamu Inoue et al.   Reproductive Biology and Endocrinology

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

(2015) N. Colombo et al.   ANNALS OF ONCOLOGY

Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients

(2015) Rong Zhou et al.   GYNECOLOGIC ONCOLOGY

European Society of Gynecological Oncology Task Force for Fertility Preservation

(2015) Alexandros Rodolakis et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Management options and fertility-preserving therapy for premenopausal endometrial hyperplasia and early-stage endometrial cancer

(2015) Gregory M. Gressel et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Pregnancy Outcomes After Fertility-Sparing Management in Young Women With Early Endometrial Cancer

(2015) Jeong-Yeol Park et al.   OBSTETRICS AND GYNECOLOGY

Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis

(2014) Martin Koskas et al.   FERTILITY AND STERILITY

The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer

(2014) Akihisa Fujimoto et al.   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

The Influence of Infertility Treatment on the Prognosis of Endometrial Cancer and Atypical Complex Endometrial Hyperplasia

(2013) Mari Ichinose et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis

(2012) Ioannis D. Gallos et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: Case series and literature review

(2011) An-Shine Chao et al.   Taiwanese Journal of Obstetrics & Gynecology

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort

(2009) I dos Santos Silva et al.   BRITISH JOURNAL OF CANCER